Vivo Opportunity Fund (Cycle III)

About Vivo Opportunity Fund (Cycle III)

Vivo Opportunity Fund (Cycle III) is a venture capital firm based in United States, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Digital Education Consumer, Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionUnited States

Funding StageSeed

Industry Focus

Deep Tech

Digital Education Consumer

Saas

Investor Signals Profile

active

Sweet Spot

Clinical-stage biotech founders in oncology or rare disease

biotech/pharma

oncology

innovative therapies

patient outcomes

healthcare access

Bullish Signals

Portfolio co acquired by Lilly $2.3Bexternal

First-in-class oncology exit achievedexternal

Multi-strategy platform: VC + PE + publicwebsite

Global healthcare ecosystem strategy activewebsite

Ecosystem strategy catalyzes innovation & growthwebsite

Contrarian Signals

Heavy focus on late-stage clinical betsexternal

Broad mandate may dilute VC focuswebsite

Founder Do's

Build first-in-class mechanisms

Target serious unmet medical needs

Advance clinical-stage programs

Expand healthcare access globally

Founder Don'ts

Avoid me-too drug approaches

Don't skip clinical validation

Avoid non-healthcare verticals

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$740M

Saves0

Website

Key People

Kevin Dai, Gaurav Aggarwal